Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sanjay R. Mohan
Observed name:
S. Mohan
Institutions:
Vanderbilt University,
Vanderbilt-Ingram Cancer Center,
Vanderbilt University Medical Center
Observed institutions:
Vanderbilt University,
Vanderbilt-Ingram Cancer Center,
Vanderbilt University Medical Center
OpenAlex ID:
A5003848800
Leukemia cutis and all-trans retinoic acid–induced myocarditis in acute promyelocytic leukemia
2026
·
Kian J. Rahbari
, Parth C. Patel
, et al.
·
Clinical Hematology International
·
1
PDF
FLAG-Ida-venetoclax in acute myeloid leukemia: real-world efficacy and the impact of venetoclax duration on outcomes
2026
·
Kateryna Fedorov
, Melanie Naranjo
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026
2026
·
Aaron T. Gerds
, Jason Gotlib
, et al.
·
Journal of the National Comprehensive Cancer Network
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia
2026
·
Somedeb Ball
, Farrukh T. Awan
, et al.
·
American Journal of Hematology
Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: PEVAZ: A PHASE II STUDY OF PEVONEDISTAT AND AZACITIDINE IN MDS AND MDS/MPN PATIENTS RELAPSED OR REFRACTORY TO DNMT INHIBITION (DNMTI)
2023
·
J. Watts
, B. Smith
, et al.
·
Leukemia Research
Show more works
View as search
Works count:
5
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type
